Canada has one of the lowest TB rates in the world. Toronto Public Health provides information on TB and recommendations for TB screening in various workplace settings within the City of Toronto. The TB program also offers consultation around TB policies and procedures.
Employees working in non-health care settings, with the exception of child care centres, shelters and detention facilities, do not have to undergo routine TB screening. If TB screening is required for contact tracing purposes, public health will contact the workplace management and facilitate the screening.
Ensure that employee confidentiality is maintained. It is important to remember that only a person with TB disease can spread the TB germs to others. People who only have a positive skin test are not sick and cannot spread TB germs. Toronto Public Health will follow up with anyone who is a contact of someone with TB disease.
A person with TB infection should not be excluded from work. People who have TB infection are not sick and cannot spread TB germs to others.
People with TB disease in the lungs or throat can spread the TB germs to other people. Therefore, it may be necessary for them to take time off work until their treatment shows that the TB germ is no longer infectious. Support from the employer is important during this time. Toronto Public Health and the employee’s physician will work closely to determine if the individual can safely report to work.
The Interferon Gamma Release Assay (IGRA), specifically the QuantiferonTB Gold (QFT) test, is a highly sensitive blood test used to determine whether a person has been infected with the tuberculosis (TB) germ, indicating‑ TB infection (latent). Unlike the TB skin test (TST), the IGRA does not cross react with the Bacille ‑CalmetteGuérin‑ (BCG) vaccine and requires only one visit. It is the preferred test for individuals who received one or more BCG vaccinations after the age of one.
In Ontario, the available IGRA test is the Quantiferon‑TB Gold (QFT), which is not currently covered by OHIP. Testing is available through:
For full recommendations on IGRA use, refer to the Canadian TB Standards (2022).
Routine annual TB skin testing (TST) or IGRA (QFT) testing is not recommended. Individuals with a previously documented positive TST or IGRA do not require repeat chest X‑rays once TB disease has been ruled out. A new chest X‑ray is only needed if symptoms develop or if there has been a recent exposure to someone with infectious TB disease.
If an infectious TB exposure occurs in a workplace, staff with a previously negative TST or IGRA may require repeat testing. Toronto Public Health coordinates all follow-up for TB exposures. TB testing is provided at no cost for individuals identified as contacts of a person with TB disease.
Early Childhood Education (ECE) field placements: Confirm with the ECE program that students have complied with the Child Care Centre TB risk assessment prior to starting their placement.
Routine TB testing in children is not recommended.
All staff must undergo a TB risk assessment. If a health care professional determines that testing is needed, they will discuss different options with the staff (e.g., TST or IGRA QFT).
Because the TST may show a false positive result in individuals who received BCG after infancy, the IGRA is preferred for those who received one or more BCG vaccinations after age one. However, a positive TST may still indicate‑ true TB infection, particularly in individuals born in, or who have travelled to, countries with high TB rates.
Routine repeat annual CXRs are not recommended. A new CXR is only necessary if the individual has symptoms suggestive of TB or has had a recent known exposure to someone with infectious TB disease. See the TB Screening for Workers in Non-Health‑ Care Settings guideline for more details.
Exposure may be identified in two ways:
Follow-up testing helps determine‑ whether infection has occurred and whether preventive treatment is recommended to reduce the risk of developing TB disease.
The Long-Term Care Homes Act, 2007 and Retirement Homes Act, 2010 require that all residents admitted to a long-term care or retirement home be screened for tuberculosis.
New TB screening recommendations for health care settings are currently being updated.